383 related articles for article (PubMed ID: 20084990)
1. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
[TBL] [Abstract][Full Text] [Related]
2. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
3. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
6. Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon.
Djouma FN; Noubom M; Ateudjieu J; Donfack H
BMC Infect Dis; 2015 Mar; 15():139. PubMed ID: 25884844
[TBL] [Abstract][Full Text] [Related]
7. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study.
Pefura-Yone EW; Kengne AP; Kuaban C
BMC Infect Dis; 2014 Mar; 14():138. PubMed ID: 24618155
[TBL] [Abstract][Full Text] [Related]
8. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Harries AD; Gausi F; Chimzizi R; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
[TBL] [Abstract][Full Text] [Related]
10. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
[TBL] [Abstract][Full Text] [Related]
11. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
12. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
[TBL] [Abstract][Full Text] [Related]
13. The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis.
Morris CD
S Afr Med J; 1996 Aug; 86(8):958-60. PubMed ID: 8823422
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
[TBL] [Abstract][Full Text] [Related]
15. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
van der Kuyp F; Mahan CS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
[TBL] [Abstract][Full Text] [Related]
16. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
17. Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
Chierakul N; Chaiprasert A; Tingtoy N; Arjratanakul W; Pattanakitsakul SN
Respirology; 2001 Dec; 6(4):305-9. PubMed ID: 11844121
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
19. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Adane K; Spigt M; Dinant GJ
BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
